KDM4C and squamous cell carcinoma: Using in vitro cell line models, KDM4C has been implicated in different cancers including squamous cell carcinoma (Cloos et al., 2006), B-cell lymphoma (Rui et al., 2010), and prostate (Wissmann et al., 2007), and breast (Liu et al., 2009) cancers.